The Food and Drug Administration (FDA) said it will oversee the destruction of nearly 200,000 units of recalled NAN OPTIPRO and NANKID OPTIPRO products as part of its regulatory supervision of the voluntary recall initiated by Nestlé Philippines, Inc.

In an update issued by the agency on Saturday, Feb. 28, the FDA said a total of 39 batches, equivalent to 330,004 units manufactured at the Cabuyao plant, were included in the precautionary recall. Production of the affected products was halted on Dec. 25, 2025.

“Approximately sixty percent of the affected products, totaling 199,414 units, are scheduled for destruction,” the FDA said.

The agency added that “one hundred percent of all segregated recalled products are now under the control of Nestlé Philippines.”

The FDA said it will directly participate in the disposal process to ensure compliance with existing regulations.

“The FDA, through its regulatory and enforcement unit, will take part in the scheduled destruction of the recalled products to ensure proper compliance with recall procedures,” it said.

With regard to consumer complaints, the agency clarified that all concerns received directly by the FDA have been referred to the company for proper handling.

“With respect to consumer concerns, as of date, all complaints received directly by the FDA have already been referred to and handled by the company. Nestlé has likewise reported that a majority of complaints received directly by it have been addressed, with continuous monitoring and follow-up,” it said.

Parents and caregivers were advised to monitor official FDA advisories and report concerns through the agency’s eSumbong platform or via email at [email protected].